Beta-score: an assessment of beta-cell function after islet transplantation.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Diabetes Care

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15677790
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beta-cell replacement therapy (pancreas and islet transplantation) for treatment of diabetes mellitus: an integrated approach.

  2004cited by this paper
• Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.

  2004cited by this paper
• The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes.

  2004cited by this paper
• Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center

  2004cited by this paper
• Transplantation of Cultured Islets from Two‐Layer Preserved Pancreases in Type 1 Diabetes with Anti‐CD3 Antibody

  2004cited by this paper
• Diagnosis and classification of diabetes mellitus.

  2004cited by this paper
• Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants.

  2003cited by this paper
• Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation1

  2003cited by this paper
• Insulin Independence Following Isolated Islet Transplantation and Single Islet Infusions

  2003cited by this paper
• Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients.

  2003cited by this paper
• Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.

  2003cited by this paper
• Diabetes Therapeutics News

  2002cited by this paper
• Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients.

  2001cited by this paper
• Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.

  1998cited by this paper
• Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass.

  1998cited by this paper

• Efficacy and Safety of Allogeneic Islet Transplantation Demonstrated by a Multicenter Clinical Trial in Japan

  2025cites this paper
• Shorter Digestion Times of Donor Islets Is Associated With Better Islet Graft Function After Islet Transplantation

  2025cites this paper
• March5-mediated Trim28 degradation preserves islet β-cell function in mice

  2025cites this paper
• [Cell therapy of diabetes in France: from islet transplantation to future perspectives].

  2025cites this paper
• Exploiting in silico modelling to enhance translation of liver cell therapies from bench to bedside

  2024cites this paper
• The First Case of Intraportal Islet Implantation During Liver Machine Perfusion Allowing Simultaneous Islet-liver Transplantation in a Human - A New and Safe Treatment for End-stage Liver Disease Combined With Diabetes Mellitus

  2024cites this paper
• Enhancing differentiation and functionality of insulin-producing cells derived from iPSCs using esterified collagen hydrogel for cell therapy in diabetes mellitus

  2024cites this paper
• Global research trends of diabetes remission: a bibliometric study

  2023cites this paper
• Islet cells in human type 1 diabetes: from recent advances to novel therapies – a symposium-based roadmap for future research

  2023cites this paper
• Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR).

  2023cites this paper
• Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.

  2023cites this paper
• Diagnosis and treatment of allograft rejection in islet transplantation.

  2023cites this paper
• Early Metabolic Measures Predict Long-term Insulin Independence in Recipients of Total Pancreatectomy and Islet Autotransplantation

  2023cites this paper
• Islets-on-Chip: A Tool for Real-Time Assessment of Islet Function Prior to Transplantation

  2023cites this paper
• Investigating the safety and efficacy of hematopoietic and mesenchymal stem cell transplantation for treatment of T1DM: a systematic review and meta-analysis

  2022cites this paper
• Pretransplant HOMA-β Is Predictive of Insulin Independence in 7 Patients With Chronic Pancreatitis Undergoing Islet Autotransplantation

  2022cites this paper
• Elevated islet prohormone ratios as indicators of insulin dependency in auto‐islet transplant recipients

  2022cites this paper
• The challenge of HLA donor specific antibodies in the management of pancreatic islet transplantation: an illustrative case-series

  2022cites this paper
• Elevated islet prohormone ratios as indicators of insulin dependency in islet transplant recipients

  2021cites this paper
• Metabolic measures before surgery and long‐term diabetes outcomes in recipients of total pancreatectomy and islet autotransplantation

  2021influential citation
• Clinical utility of C‐peptide measurement after pancreas transplantation with especial focus on early graft thrombosis

  2021cites this paper
• Indications for islet or pancreatic transplantation: Statement of the TREPID working group on behalf of the Société francophone du diabète (SFD), Société francaise d'endocrinologie (SFE), Société francophone de transplantation (SFT) and Société française de néphrologie – dialyse – transpl

  2021cites this paper
• The long noncoding RNA MALAT1 predicts human islet isolation quality

  2021cites this paper
• Considerations and Challenges of Islet Transplantation and Future Therapies on the Horizon.

  2021cites this paper
• Clinically available immunosuppression averts rejection but not systemic inflammation after porcine islet xenotransplant in cynomolgus macaques

  2021cites this paper
• Effects of islet transplantation on microvascular and macrovascular complications in type 1 diabetes

  2021cites this paper
• The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program

  2021cites this paper
• Ten‐year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss‐French GRAGIL network

  2021cites this paper
• Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation

  2021cites this paper
• Characterization of Daily Glycemic Variability in Subjects with Type 1 Diabetes Using a Mixture of Metrics

  2020cites this paper
• Randomized 52-week Phase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes.

  2020cites this paper
• Fasting parameters for estimation of stimulated β cell function in islet transplant recipients with or without basal insulin treatment

  2020cites this paper
• Pancreatic Islet Cell Transplantation: Graft Stability and Metabolic Outcomes

  2020cites this paper
• Indications for islet or pancreatic transplantation: Statement of the TREPID working group on behalf of the Société francophone du diabète (SFD), Société francaise d'endocrinologie (SFE), Société francophone de transplantation (SFT) and Société française de néphrologie - dialyse - transplantation (S

  2019cites this paper
• Change in Functional Beta Cell Capacity With Time Following Autologous Islet Transplantation

  2019cites this paper
• Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study

  2019cites this paper
• Analyse des scores de variabilité glycémique dans une population de patients diabétiques de type 1 avant et après transplantation d’ilots pancréatiques et apport dans le diagnostic de succès de greffe

  2019cites this paper
• Assessment of plasma microvesicles to monitor pancreatic islet graft dysfunction: Beta cell‐ and leukocyte‐derived microvesicles as specific features in a pilot longitudinal study

  2019cites this paper
• Persistent C‐peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?

  2019cites this paper
• The long noncoding RNA MALAT1 predicts human pancreatic islet isolation quality.

  2019cites this paper
• BETA‐2 score is an early predictor of graft decline and loss of insulin independence after pancreatic islet allotransplantation

  2019cites this paper
• Glycemic variability indices can be used to diagnose islet transplantation success in type 1 diabetic patients

  2019cites this paper
• Defining Outcomes for &bgr;-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop

  2018cites this paper
• Does Islet Size Really Influence Graft Function After Clinical Islet Transplantation?

  2018influential citation
• Liver transaminase levels after intraportal autologous islet transplantation after partial pancreatectomy were associated with long-term metabolic outcomes.

  2018cites this paper
• Comparison of metabolic responses to the mixed meal tolerance test vs the oral glucose tolerance test after successful clinical islet transplantation

  2018cites this paper
• Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after islet transplantation

  2018cites this paper
• Defining outcomes for β‐cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop

  2018cites this paper
• Integration of Routine Parameters of Glycemic Variability in a Simple Screening Method for Partial Remission in Children with Type 1 Diabetes

  2018cites this paper
• Effect of intrapancreatic fat on diabetes outcomes after total pancreatectomy with islet autotransplantation

  2018cites this paper
• [Transplantation strategy in type 1 diabetic patients].

  2018cites this paper
• Does islet size really influence graft function following clinical islet transplantation?

  2018influential citation
• Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.

  2018cites this paper
• Purity of islet preparations and 5‐year metabolic outcome of allogenic islet transplantation

  2018cites this paper
• Islet transplantation in type 1 diabetes: moving forward.

  2018cites this paper
• Clinical implications of persistent beta cell function in long duration type 1 diabetes

  2018cites this paper
• The BETA-2 Score: a Tool for Assessing Beta Cell Function in Clinical Islet Transplantation and Type 1 Diabetes Intervention Trials

  2017cites this paper
• Preparation, calibration and evaluation of the First International Standard for human C-peptide

  2017cites this paper
• Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections

  2017cites this paper
• Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress

  2017cites this paper
• Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection

  2017cites this paper
• Multicenter Assessment of Animal-free Collagenase AF-1 for Human Islet Isolation

  2017cites this paper
• External Validation of the Newly Developed BETA-2 Scoring System for Pancreatic Islet Graft Function Assessment.

  2017influential citation
• Pancreatic Islet Transplantation Technologies: State of the Art of Micro- and Macro-Encapsulation

  2017cites this paper
• Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations

  2017cites this paper
• Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress

  2017cites this paper
• Clinical pancreatic islet transplantation

  2017cites this paper
• Quantifying Insulin Therapy Requirements to Preserve Islet Graft Function following Islet Transplantation

  2016cites this paper
• Glycemic Stability Through Islet‐After‐Kidney Transplantation Using an Alemtuzumab‐Based Induction Regimen and Long‐Term Triple‐Maintenance Immunosuppression

  2016cites this paper
• Outcomes of Pancreatic Islet Allotransplantation Using the Edmonton Protocol at the University of Chicago

  2016cites this paper
• Monitoring of beta cell replacement outcomes.

  2016cites this paper
• Validation of the BETA‐2 Score: An Improved Tool to Estimate Beta Cell Function After Clinical Islet Transplantation Using a Single Fasting Blood Sample

  2016cites this paper
• Alloimmune Monitoring after Islet Transplantation: A Prospective Multicenter Assessment of 25 Recipients

  2016cites this paper
• Standards , Policies , Protocols , and Regulations for Cell-Based Therapies Residual b-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation

  2016cites this paper
• Residual β‐Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation

  2016cites this paper
• CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes

  2015cites this paper
• Progress of Islet Transplantation over the Last 15 Years

  2015cites this paper
• Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network

  2015cites this paper
• Islet transplantation from a nationally funded UK centre reaches socially deprived groups and improves metabolic outcomes

  2015influential citation
• Hepatic steatosis after islet transplantation: Can ultrasound predict the clinical outcome? A longitudinal study in 108 patients.

  2015cites this paper
• Metabolic outcomes of islet transplantation and correlation of graft function with hepatic imaging and immune response

  2015influential citation
• Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experience

  2014cites this paper
• Serum C-peptide assay of patients with hyperglycemic emergencies at the Lagos State University Teaching Hospital (LASUTH), Ikeja

  2014cites this paper
• Home Urine C-Peptide Creatinine Ratio Can Be Used to Monitor Islet Transplant Function

  2014cites this paper
• Continuous Glucose Monitoring Analysis as Predictor of Islet Yield and Insulin Requirements in Autologous Islet Transplantation After Complete Pancreatectomy

  2014cites this paper
• Pancreas transplantation: solid organ and islet.

  2014cites this paper
• Has the Gap Between Pancreas and Islet Transplantation Closed?

  2014cites this paper
• Liver Perfusion Changes Occurring During Pancreatic Islet Engraftment: A Dynamic Contrast‐Enhanced Magnetic Resonance Study

  2014cites this paper
• Impact of Anti–Insulin Antibodies on Islet Transplantation Outcome: Data From the GRAGIL Network

  2014cites this paper
• Demonstration of an Intrinsic Relationship Between Endogenous C-Peptide Concentration and Determinants of Glycemic Control in Type 1 Diabetes Following Islet Transplantation

  2014cites this paper
• Monitoring of clinical islet transplantation.

  2013cites this paper
• The clinical utility of C-peptide measurement in the care of patients with diabetes

  2013cites this paper
• Beta Cell Function After Islet Transplantation

  2013cites this paper
• LC-MS/MS identification of doublecortin as abundant beta cell-selective protein discharged by damaged beta cells in vitro.

  2013cites this paper
• Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients

  2013cites this paper
• DB121507 2683..2688

  2013cites this paper
• Potential of Protein Phosphatase Inhibitor 1 As Biomarker of Pancreatic β-Cell Injury In Vitro and In Vivo

  2013cites this paper
• Use of Glucagon-Like Peptide-1 Agonists to Improve Islet Graft Performance

  2013cites this paper
• Abdominal Organ Transplantation Abdominal Organ Transplantation State of the Art

  2012cites this paper
• Comparative Impact on Islet Isolation and Transplant Outcome of the Preservation Solutions Institut Georges Lopez-1, University of Wisconsin, and Celsior

  2012cites this paper